Βενζοξικό οξύ, 4-φθορο-αλφα- ((1-μεθυλεθυλο) -, (.αλφα.S) - (830346-47-9)
Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- is a key intermediate of Elagolix Sodium. Product Name: Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- CAS No.: 830346-47-9 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H10F4N2O2 Molecular Weight: 302.22 Shelf Life: 2 Years Package: 25kg/drum
Elagolix Sodium (832720-36-2)
Elagolix sodium (ABT-620) is a small molecule, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It has the ability to suppress estradiol (E2) concentrations in a dose-dependent manner. Elagolix is the first orally available GnRH antagonist, and as such may provide patients with relief from the painful symptoms of endometriosis while offering advantages over currently available injectable peptide-based treatments. The estimated patient population is
2-φθορο-3-μεθοξυφαινυλοβορονικό οξύ (352303-67-4)
2-fluoro-3-methoxyphenylboronic acid is an intermediate of Elagolix Sodium. Product Name: 2-fluoro-3-methoxyphenylboronic acid CAS No.: 352303-67-4 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C7H8BFO3 Molecular Weight: 169.95 Shelf Life: 2 Years Package: 25kg/drum
